Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs180177042
rs180177042
T 0.700 GeneticVariation CLINVAR

dbSNP: rs387906660
rs387906660
A 0.700 CausalMutation CLINVAR

dbSNP: rs387906661
rs387906661
G 0.700 CausalMutation CLINVAR

dbSNP: rs397507466
rs397507466
G 0.700 GeneticVariation CLINVAR

dbSNP: rs397516895
rs397516895
T 0.700 GeneticVariation CLINVAR

dbSNP: rs113488022
rs113488022
0.750 GeneticVariation BEFREE V599E BRAF mutation was uncommon in Japanese lung cancer. 16376942

2006

dbSNP: rs121913377
rs121913377
0.050 GeneticVariation BEFREE V599E BRAF mutation was uncommon in Japanese lung cancer. 16376942

2006

dbSNP: rs113488022
rs113488022
T 0.750 CausalMutation CLINVAR A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. 22743296

2012

dbSNP: rs113488022
rs113488022
0.750 GeneticVariation BEFREE Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer. 29348459

2018

dbSNP: rs121913377
rs121913377
0.050 GeneticVariation BEFREE Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer. 29348459

2018

dbSNP: rs121913351
rs121913351
A 0.800 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs113488022
rs113488022
T 0.750 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs1057519719
rs1057519719
C 0.700 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs1057519720
rs1057519720
AA 0.700 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs121913355
rs121913355
G 0.700 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs121913369
rs121913369
C 0.700 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210

2009

dbSNP: rs113488022
rs113488022
0.750 GeneticVariation BEFREE BRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear. 24035431

2013

dbSNP: rs121913377
rs121913377
0.050 GeneticVariation BEFREE BRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear. 24035431

2013

dbSNP: rs121913351
rs121913351
A 0.800 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs113488022
rs113488022
T 0.750 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs1057519719
rs1057519719
C 0.700 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs1057519720
rs1057519720
AA 0.700 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs121913355
rs121913355
G 0.700 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs121913369
rs121913369
C 0.700 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918

2002

dbSNP: rs121913369
rs121913369
C 0.700 CausalMutation CLINVAR BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. 22798288

2012